Lacrivera

Join us at the ZEISS Ophthalmic Digital Summit 2019

AdminWolf

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
17,378
3,727
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
I'm happy to announce our second annual online collaboration with ZEISS!

ZEISS OPHTHALMIC DIGITAL SUMMIT 2019
ONLINE July 20 and July 21 | 11am EST to 2pm EST
https://www.ods2019.com/

Register Here (totally free!)


EVENT SUMMARY

In partnership with ODwire.org, Carl Zeiss Meditec, Inc. and Carl Zeiss Vision invite you to the ZEISS Ophthalmic Digital Summit 2019. This two-day complimentary online program offers live sessions and an interactive product showcase—all within a virtual exhibit hall—designed to provide you with the latest technology innovations and clinical solutions for your practice.

Taught by industry leaders, you'll get trained and informed on how the Integrated Diagnostic Imaging platform and ZEISS leading imaging technologies will help shape the future of your practice.

Event attendees will also be eligible for special show promotions and discounts on ZEISS instruments.


All-access complimentary pass
Your registration gives you access to unparalleled content. Here's what you can expect at the ZEISS Ophthalmic Digital Summit 2019:

  • Attend six live sessions with interactive Q&A presented by industry experts. Chat live with presenters during their sessions.
  • Learn about the Integrated Diagnostic Imaging platform from ZEISS, new glaucoma and retina management tools, wavefront digital refraction and how together they will help your practice grow.
  • Explore a virtual exhibit hall showcasing the latest technology and products from ZEISS.
  • View product video demos on the CIRRUS™ HD-OCT, CLARUS®500 UWF Fundus Imaging, HFA Perimetry, i.ProfilerPlus, ZEISS Digital SRU system and more.
  • Chat live with the ZEISS sales team to learn more about our product portfolio and show specials.
  • Livestream with Drs. Paul and Adam Farkas with interviews and updates throughout the event
  • 30 Days of On-Demand. Did you miss that session? No problem! Catch it On Demand after the live broadcast.
Special Show Promotions and Discounts!
Don't forget to register for access to all of the ZEISS articles, videos, sessions and special price promotions!

Register Here


Agenda

OCT Retinal Bootcamp
Dan Epshtein, OD, FAAO

Dr. Epshtein dives into practical uses of OCT technology including the OCT concept, types of OCT scans, their interpretation and detection of normal vs. signs of pathology. Clinical cases will be presented to demonstrate the use and interpretation of OCT for diagnosing common diseases as well as masquerader pathology.


New Trends and Practices in the Diagnosis and Management of Glaucoma
Murray Fingeret, OD, FAAO; John Flanagan, PhD, Dsc (hon), FCOptom, FAAO, FARVO

Dr. Fingeret and Prof. Flanagan share their insights regarding best practices in glaucoma diagnosis and management based on recent innovations.

Benefits of using the new SITA™ Faster test strategy and 24-2C test pattern are presented and the methodology evolution from SITA Standard to SITA Fast to SITA Faster is discussed. The presentation includes clinical cases that highlight benefits of using SITA Faster 24-2C.


Ultra-widefield 2.0: HD True Color Imaging
Kevin L.Gee, OD, FAAO, Diplomate, ABO; Dan Epshtein, OD, FAAO

Dr. Gee and Dr. Epshtein provide valuable insight on how ODs are implementing the latest technology in ultra-widefield imaging into their practice, enhancing both patient care and patient education.

Cases will be presented highlighting the clinical value of true color, high-resolution imaging from the ZEISS CLARUS 500 and how it can aid in detecting and diagnosing the full spectrum of eye disease, from the periphery to the macula, optic nerve head and anterior segment.


Glaucoma Progression – Putting the Pieces All Together
Michael Chaglasian, OD, FAAO; Murray Fingeret, OD, FAAO

Dr. Fingeret and Dr. Chaglasian discuss the importance of detecting glaucoma progression and the rate of progression when managing glaucoma and making decisions about treating a patient, changing medication or referring a patient to a glaucoma specialist.

When managing a glaucoma patient, longitudinal sets of multi-dimensional, multi-modality data must be used in combination. Glaucoma Workplace is a platform that integrates OCT structure and Visual Field function, bringing together test of both types in Guided Progression Analysis (GPA™) to help determine if glaucoma is in a stable condition or progressing, and at what rate.


OCT Angiography: Routine to Extreme
Carolyn E. Majcher, OD, FAAO; Elizabeth A. Steele, OD, FAAO

Dr. Steele and Dr. Majcher review OCT Angiography (OCTA) technology, its implementation in OCT devices and practical considerations for using OCTA as a complementary modality that may aid in revealing or confirming early signs of disease and assist in the diagnosis and management of retina diseases, such as diabetic retinopathy, AMD and vascular pathology. Novel applications for tracking changes in glaucoma based on capillary blood flow parameters are also discussed.


Getting Ahead of the Wave(front) – Digital Refraction in Practice
Benito Peña, OD

Valuable insights and case studies on the use of wavefront HOA objective refraction data in combination with ZEISS digital phoropter technology to speed workflow and help to improve patient outcomes.

Discussing principles, and usability, this course highlights how ZEISS i.Scription can aid in the resolution of difficult patient acuity challenges while adding practice revenue.

Learn more & Register!
 
Looking forward to what should be a fun event.

I'll have more details about the types of discounts that Zeiss will be able to offer at the show ASAP. (Some won't be broadly advertised though -- so register if you are at all in the market for new equipment. It's free to sign up!)
 
AdminWolf said:
Looking forward to what should be a fun event.

I'll have more details about the types of discounts that Zeiss will be able to offer at the show ASAP. (Some won't be broadly advertised though -- so register if you are at all in the market for new equipment. It's free to sign up!)
Click to expand...
Adam,

Do you know if the program will also be "on demand"? I'm on business travel on those two days.
 
Richard_Hom said:
Adam,

Do you know if the program will also be "on demand"? I'm on business travel on those two days.
Click to expand...

Yes, as of right now the plan is to put the show on demand for 30 days post-event. I'll keep everyone up-to-date in this thread if plans change.

-- ad
 
Someone emailed me with a question about the content at the event; these are all-new lectures, none are retreads from prior years.

Obviously this has a more commercial bent (since Zeiss is running this with us), but whether you use their devices or someone else's the content on glaucoma, OCT interpretation, etc, is generally useful.

 
A press release where additional information may be available from Zeiss representatives at their virtual exhibitors booth...

Zeiss Receives FDA Clearance for Clarus 700 Ultra-Widefield Imaging Device
Source: Zeiss
Clarus 700FDA ClearanceFluorescein AngiographyUltra-Widefield ImagingZeiss

Zeiss announced that it has received FDA 510(K) clearance for the Clarus 700, high-definition, ultra-widefield imaging system. Clarus 700 is the first high-resolution ultra-widefield imaging with true color and a complete range of fundus imaging modalities, including fluorescein angiography, according to a company news release.

Ultra-widefield fluorescein angiography helps eye care specialists identify earlier more severe forms of diabetic retinopathy like neovascularization and retinal diseases such as uveitis, choroidal masses, retinal tears, detachments, and peripheral ischemia.

The high-resolution and high contrast images of the fluorescein angiography from the Clarus 700 allows clinicians to capture the smallest details from the macula in early phase to the periphery in late phase of fluorescein angiography. Powered by Zeiss’ “Broadline Fundus Imaging” the Zeiss Clarus 700 captures images that closely resemble the natural coloration of the fundus as it appears under direct clinical observation, according to Zeiss.

“I think the main goal of any fundus imaging system is to really get the pan-retinal view of the retina in true color. That’s where I think Clarus is going to make some major steps in that direction,” Jesse Jung, MD, from East Bay Retina Consultants, said in a company news release.

Using a simple and intuitive interface with time-saving data acquisition features, the Clarus 700 provides a comprehensive fundus exam that aids in diagnoses, treatment planning, and disease management. With its new features using deep learning algorithms, retina specialists can maximize the workflow efficiency in their practice and image all patient types including elderly and sick who may have trouble maintaining their fixation.

“Zeiss has been at the forefront of industry-defining advancements that have made Clarus the industry’s standard of care for identifying retinal and glaucoma disease,” Jim Mazzo, Global President of Ophthalmic Devices at Carl Zeiss Meditec, said in the news release. “From early detection to post-operative evaluation, we’re here to support our customers, every step of the way.”

With the Clarus 700, advanced care specialists can manage all needed capture modalities including: True color with RGB separation, autofluorescence-green, autofluorescence-blue, stereo image pairs, external eye and fluorescein angiography in one session from one device, all without having to reposition the patient, thus providing patients a comfortable exam experience.
 
Paul Farkas said:
A press release where additional information may be available from Zeiss representatives at their virtual exhibitors booth...

Zeiss Receives FDA Clearance for Clarus 700 Ultra-Widefield Imaging Device
Source: Zeiss
Clarus 700FDA ClearanceFluorescein AngiographyUltra-Widefield ImagingZeiss

Zeiss announced that it has received FDA 510(K) clearance for the Clarus 700, high-definition, ultra-widefield imaging system. Clarus 700 is the first high-resolution ultra-widefield imaging with true color and a complete range of fundus imaging modalities, including fluorescein angiography, according to a company news release.

Ultra-widefield fluorescein angiography helps eye care specialists identify earlier more severe forms of diabetic retinopathy like neovascularization and retinal diseases such as uveitis, choroidal masses, retinal tears, detachments, and peripheral ischemia.

The high-resolution and high contrast images of the fluorescein angiography from the Clarus 700 allows clinicians to capture the smallest details from the macula in early phase to the periphery in late phase of fluorescein angiography. Powered by Zeiss’ “Broadline Fundus Imaging” the Zeiss Clarus 700 captures images that closely resemble the natural coloration of the fundus as it appears under direct clinical observation, according to Zeiss.

“I think the main goal of any fundus imaging system is to really get the pan-retinal view of the retina in true color. That’s where I think Clarus is going to make some major steps in that direction,” Jesse Jung, MD, from East Bay Retina Consultants, said in a company news release.

Using a simple and intuitive interface with time-saving data acquisition features, the Clarus 700 provides a comprehensive fundus exam that aids in diagnoses, treatment planning, and disease management. With its new features using deep learning algorithms, retina specialists can maximize the workflow efficiency in their practice and image all patient types including elderly and sick who may have trouble maintaining their fixation.

“Zeiss has been at the forefront of industry-defining advancements that have made Clarus the industry’s standard of care for identifying retinal and glaucoma disease,” Jim Mazzo, Global President of Ophthalmic Devices at Carl Zeiss Meditec, said in the news release. “From early detection to post-operative evaluation, we’re here to support our customers, every step of the way.”

With the Clarus 700, advanced care specialists can manage all needed capture modalities including: True color with RGB separation, autofluorescence-green, autofluorescence-blue, stereo image pairs, external eye and fluorescein angiography in one session from one device, all without having to reposition the patient, thus providing patients a comfortable exam experience.
Click to expand...
Will these lectures have COPE approval?
 
Steve Shum said:
Will these lectures have COPE approval?
Click to expand...
Unfortunately not. The speakers are offering great material but will also be discussing Zeiss products. Zeiss is paying the bill for the show .

As a result there is no charge for the education. The exhibit hall will be offering show discounts as if you attended in a Bricks and Mortar meeting.

Nothing to lose and education to gain.
 
Adam and I will be doing a live chat during the show on 7/20 and 7/21 from 11am ET- 2 PM ET (8am PT- 11am PT).

We shall have some of speakers giving the presentations sharing insights on their presentation and possibly other topics.

Do you want to share some thoughts with Adam or myself? Send me a Private Message with your phone number and we'll schedule a time. No worries about COPE approval. Your decision on what you would like to discuss.
 
Paul Farkas said:
Unfortunately not. The speakers are offering great material but will also be discussing Zeiss products. Zeiss is paying the bill for the show .

As a result there is no charge for the education. The exhibit hall will be offering show discounts as if you attended in a Bricks and Mortar meeting.

Nothing to lose and education to gain.
Click to expand...

To clarify --

COPE doesn't allow a single company to sponsor an entire COPE-approved CE event -- the conflict of interest is too great.

Sometimes you'll see individual companies sponsoring a dinner or something similar through the use of a grant given to a third party who produces the event, but there are restrictions on what the company can and can't do (ie -- in those cases, the company can't dictate who the speaker is, or what they talk about, or even where the event is held. Corporate staff has to leave the area where the education is taking place -- they can't even be in the same room as the rest of the docs, etc...) It is a challenge to produce such an event (we've done it before, but ugh...)

Anyway, for online programs you will rarely (if ever) see a single company sponsored COPE approved materials, and if you do, it is likely they are in violation.
 
Just a reminder that the ZEISS Ophthalmic Digital Summit is coming up tomorrow -- see more details here.

The Livestream will also be broadcast here on ODwire.org, Paul and I will be interviewing folks as usual and describing the blow-by-blow of what's happening at the conference.

Hope to see you there!

ad
 
Right, or just refresh the page at https://www.ods2019.com , the login link is right at the top now.

(We open the conference 30 minutes before the first lecture starts.)
 
This your final week to take advantage of some great education and Zeiss show discounts.

The show closes on 8/20/19.
 
You must log in or register to reply here.
LENZ REleases Positive Phase 3 Presbyopia Data
Top Bottom
Back
Home
Forums
Webinars
Menu